The effectiveness of carboxytherapy in reducing the thickness of abdominal subcutaneous fat.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: BMI = 25 kg/m2 Waist circumference greater than 102 Cm in men and 88 Cm in women Waist/Hip ratio greater than 0.9 in men and 0.85 in women Abdominal sagging
Exclusion criteria
Exclusion criteria: Pregnancy Breast feeding History of smoking, alcohol and drug abuse Medication (also including supplimentary agents) within 6 weeks before the study initiation Any lipolytic treatment or procedure at the site of study within one year before the study initiation Any systemic disorder such as diabetes mellitus, kidney diseases, cardiac diseases, respiratory diseases, liver diseases, severe anemia, etc. Using diluent and anticonvulsant drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical evaluation objectively and subjectively. Timepoint: Time 0, before each session and 2 weeks after the last session. Method of measurement: Visual and photographic findings.;BMI. Timepoint: Time 0, before each session and two weeks after the last session. Method of measurement: Meters and scales.;Waist circumference. Timepoint: Time 0, before each session and two weeks after the last session. Method of measurement: Meter.;Waist/hip ratio. Timepoint: Time 0, before each session and two weeks after the last session. Method of measurement: Meter.;Abdominal subcutaneous fat thickness and density. Timepoint: 2 weeks after the last session. Method of measurement: Ultrasound machine. | — |
Countries
Iran (Islamic Republic of)
Contacts
Arak University of Medical Sciences